| LINE ITEM (USD / %) | FY 2025
FILED 2025-07-26 | FY 2024
FILED 2024-07-27 | FY 2023
FILED 2023-07-29 |
|---|---|---|---|
| Revenue (Total Sales) | $2.32B | $2.24B | $2.17B |
| YoY Revenue Growth % | +3.8% | +3.2% | — |
| Gross Profit | $663.0M | $642.0M | — |
| Gross Margin % | 28.6% | 28.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $72.1M | $62.1M | $65.5M |
| Operating Margin % | 3.1% | 2.8% | 3.0% |
| Net Income (GAAP) | $56.4M | $50.5M | $49.7M |
| EBITDA (Normalized) | $119.1M | $112.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $93.3M | $80.9M | $104.5M |
| Capital Expenditures (CapEx) | $58.8M | $63.1M | — |
| Free Cash Flow (FCF) | $34.5M | $17.8M | $104.5M |
| FCF Margin % | 1.5% | 0.8% | 4.8% |
| Return on Invested Capital (ROIC %) | 14.0% | 12.5% | — |
| Cash & Short-Term Equivalents | $160.1M | $133.9M | — |
| Total Debt (Short + Long Term) | $49.5M | $53.1M | — |
| Total Stockholders' Equity | $516.7M | $472.0M | — |